Pancreatitis and Duodenitis from Sarcoidosis: Successful Therapy with Mycophenolate Mofetil

Digestive Diseases and Sciences

Volumn 48, Issue 11, 2003, Pages 2191-2195

  O' Connor, Andrew S ^b   Navab, Farhad ^b   Germain, Michael J ^b   Freeman, Jonathan K ^b   Mulhern, Jeffrey G ^b   O'Shea, Michael H ^b   Lipkowitz, George S ^b   Madden, Robert L ^b   Braden, Gregory L ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Duodenitis; Mycophenolate; Pancreatitis; Sarcoidosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IOTALAMATE SODIUM; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; PREDNISONE;

ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ACUTE PANCREATITIS; ADULT; ARTICLE; ASEPTIC NECROSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIAGNOSTIC APPROACH ROUTE; DRUG HYPERSENSITIVITY; DUODENITIS; ENDOSCOPY; GLOMERULONEPHRITIS; HUMAN; LABORATORY TEST; MALE; PANCREAS BIOPSY; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SARCOIDOSIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUODENITIS; HUMANS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREATITIS; SARCOIDOSIS;

EID: 0347416945     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000004525.62906.29     Document Type: Article

References (40)

1. Newman LS, Rose CS, Maier LA: Sarcoidosis. N Engl J Med 336:1224-1234, 1997
2. Casella FJ, Allon M: The kidney in sarcoidosis. J Am Soc Nephrol 3:1555-1562, 1993
3. Sprague R, Harper P, McClain S, Trainer T, Beeken W: Disseminated gastrointestinal sarcoidosis. Gastroenterology 87:421-425, 1984
4. Rauf A, Davis P, Levendoglu H: Sarcoidosis of the small intestine. Am J Gastroenterol 83(2):187-189, 1988
5. Chaun H, King DM, Gofton JS, Sutherland WH, Bogoch A: Sarcoidosis of the pancreas. Dig Dis 17:725-730, 1972
6. Friedman HZ, Weinstein RA: Sarcoidosis of the pancreas. Arch Intern Med 143:2182-2183, 1983
7. Snook B, Duggan M, Birkett D: Sarcoidosis of the pancreas: a case report. Am Surg 62:947-948, 1996
8. Frank JL, Goldman M, Nathanson I, Pierangelo D, Kaufman JL, Freeman JK, Reed WP: Surgical management of pancreatic sarcoidosis. Surg Rounds 13:641-646, 1999
9. Bruns FJ, Adler S, Fraley DS, Segel DP: Long-term follow-up of aggressively treated idiopathic rapidly progressive glomerulonephritis. Am J Med 86:400-406, 1989
10. Stilmant MM, Bolton WK, Sturgill BC, Schmitt GW, Couser WG: Crescentic glomerulonephritis without immune deposits: clinicopathologic features. Kidney Int 15:184-195, 1979
11. Couser WG: Idiopathic rapidly progressive glomerulonephritis. Am J Nephrol 2:57-69, 1982
12. Correa P: Sarcoidosis associated glomerulonephritis. Arch Pathol 57:523-529, 1954
13. Goldszer RC, Galvanek EG, Lazarus M: Glomerulonephritis in a patient with sarcoidosis. Arch Pathol Lab Med 105:478-481, 1981
14. Taylor TK, Senekjian HO, Knight TF, Gyorkey F, Weinman EJ. Membranous nephropathy with epithelial crescents in a patient with pulmonary sarcoidosis. Arch Intern Med 139:1183-1185, 1979
15. Shintaku M, Mase K, Ohtsuki H, Yasumizu R, Yasunaga K, Ikehara S: Generalized sarcoidlike granulomas with systemic angiitis, crescentic glomerulonephritis, and pulmonary hemorrhage. Arch Pathol Lab Med 113:1295-1298, 1989
16. Ahuja TS, Mattana J, Valderrama E, Sankaran R, Singhal PC, Wagner JD: Wegener's granulomatosis followed by development of sarcoidosis. Am J Kidney Dis 28(6):893-898, 1996
17. Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 299:153-157, 1990
18. Lower EE, Baughman RP: Prolonged use of methothrexate sarcoidosis. Arch Intern Med 155:846-851, 1995
19. Laye P, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 34:642-644, 1995
20. Zabel P, Entzian P, Dalhoff K, Schlaak M: Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med 155:1665-1669, 1997
21. Marton J, Farkes G, Takacs T, Nagy Z, Szasz Z, Varga J, Jarmay K, Bologh A, Lonovics J: Beneficial effects of pentoxifylline treatment of experimental acute pancreatitis in rats. Res Exp Med 197:293-299, 1998
22. Fomochkin IL, Kazakova VV, Kolbesin PN: Clinical effectiveness of trental and thiotriazolinum in the treatment of acute pancreatitis. Klin Khir 10:10-12, 1999
23. Siwach V, Bansal V, Kumar A, Rao Ch U, Sharma A, Minz M: Post-renal transplant azathioprine-induced pancreatitis. Nephrol Dial Transplant 14:2495-2498, 1999
24. Tragone A, Bazzoechi G, Aversa G, Percorelli MG, Elmi G, Venerato S: Acute pancreatitis after azathioprine treatment for ulcerative colitis. Ital J Gastroenterol 28:10204, 1996
25. Chan TM, Li FK, Tang CSO, Wong RWS, Fang GX, Ji YL, Lau CS, Wong AKM, Tong MKL, Chan KWC, Lai KN: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 343:1156-1162, 2000
26. Glicklich D, Acharya A: Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis 32(2):318-322, 1998
27. Briggs WA, Choi MJ, Scheel PJ Jr: Successful mycophenolate mofetil treatment of glomerular diseases. Am J Kidney Dis 31(2):213-217, 1998
28. Miller G, Zimmerman R, III, Radhakrishnan J, Aooel G: Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 36(2):250-256, 2000
29. Kataria YP, Holter JF: Immunology of sarcoidosis. Clin Chest Med 18(4):719-739, 1997
30. Du Bois RM, Kirby M, Balbi B, Saltini C, Crystal RG: T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the t-cell antigen receptor. Am Rev Respir Dis 145:1205-1211, 1992
31. Agostini C, Basso U, Semenzato G: Cells and molecules involved in the development of sarcoid granuloma. J Clin Immunol 18(3): 184-192, 1998
32. Bolton WK, Innes, Jr, DJ, Sturgill BC, Kaiser DL: T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int 32:869-876, 1987
33. Holdsworth SR, Kitching AR, Tipping PG: Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 55:1198-1216, 1999
34. Li HL, Hancock WW, Dowling JP, Atkins RC: Activated intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 39:793-798, 1991
35. Cohen JJ, Harrington JT, Madias NE: Interlukin-1 in crescentic glomerulonephritis. Kidney Int 48:576-586, 1995
36. Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY: Modulators of crescentic glomerulnephritis. J Am Soc Nephrol 7:2271-2278, 1996
37. Weber LT, Shipkova M, Lamersdorf T, Niedman PD, Wiesel M, Mandelbaum A, Zimmerhackl LB, Schutz E, Mehls O, Oellerich M, Armstrong VW, Tonshoff B: Pharmacokinetics of mycophenolic acid and determinants of MPA free fraction in pediatric and adult renal transplant recipients. J Am Soc Nephrol 9:1511-1520, 1998
38. Gummert JF, Ikonen T, Morris RE: Newer immunosuppressive drugs: a review. J Am Soc Nephrol 10:1366-1380, 1999
39. Bolton WK: Treatment of glomerular diseases: ANCA-negative RPGN. Semin Nephrol 20(3):244-255, 2000
40. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, Van Der Woude FJ. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 10:1965-1971, 1999